InflaRx IFRX
NASDAQ IFRX
$1.55 +0.01 (+0.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Current Deferred Revenue (2016 - 2018)

Updated

InflaRx's Current Deferred Revenue was $13,958 in Q3 2018, down 25.8% from $18,801 a year earlier and down 10.0% from the prior quarter.

Analysis

InflaRx (IFRX) Current Deferred Revenue (2016 - 2018) Analysis & Trends

At the end of FY2017, Current Deferred Revenue at InflaRx came in at $16,940, down 19.5% from FY2016.

  • In earlier years, Current Deferred Revenue was $21,034 in FY2016.
  • Per Business Quant data, IFRX's Current Deferred Revenue in the three quarters before Q3 2018 was $15,515 (Q2 2018), $17,199 (Q1 2018) and $17,661 (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 InflaRx 104.63 Mn -228.98 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 13,964.85
Jun 30, 2018 15,031.86
Mar 31, 2018 17,223.99
Dec 31, 2017 17,912.59
Sep 30, 2017 18,850.81
Dec 31, 2016 20,093.06
API Access

InflaRx Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IFRX&period=max&api_key=YOUR_API_KEY